|
000
| 01865nam 2200361zi 4500 |
|---|
| 001 | 9.877008 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107164846 |
|---|
| 006 | m o d f |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 190725s20202020onc o f000 0 eng d |
|---|
| 020 | |a9780660319933 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH164-287/2019E-PDF |
|---|
| 245 | 00|aFecal microbiota therapy used in the treatment of Clostridium difficile infection not responsive to conventional therapies : |bguidance document. |
|---|
| 264 | 1|a[Ottawa] : |bHealth Canada = Santé Canada,|c2020. |
|---|
| 264 | 4|c©2020 |
|---|
| 300 | |a1 online resource (11 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |a"Publication date: March 2020." |
|---|
| 500 | |a"Date adopted: 2015-03-27; effective date: 2015-03-27; revised Date: 2020-03-27." |
|---|
| 500 | |aIssued also in French under title: Bactériothérapie fécale utilisée dans le traitement de l’infection à Clostridium difficile qui ne répond pas aux traitements classiques. |
|---|
| 500 | |aIssued also in HTML format. |
|---|
| 650 | 0|aClostridium difficile|xTreatment|zCanada. |
|---|
| 650 | 0|aFeces|xMicrobiology|zCanada. |
|---|
| 710 | 1 |aCanada. |bHealth Canada. |
|---|
| 775 | 08|tBactériothérapie fécale utilisée dans le traitement de l’infection à Clostridium difficile qui ne répond pas aux traitements classiques : |w(CaOODSP)9.877010 |
|---|
| 856 | 40|qPDF|s274 KB|uhttps://publications.gc.ca/collections/collection_2020/sc-hc/H164-287-2019-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/regulation-fecal-microbiota-therapy-treatment-difficile-infections.html |
|---|